Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | USP8 | P40818 | 1/20 | 0.38 |
| ▸ | USP5 | P45974 | 1/20 | 0.38 |
| ▸ | USP4 | Q13107 | 1/20 | 0.38 |
| ▸ | USP7 | Q93009 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | WDR5 | P61964 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22101374 | 0.80 | CYP11B1 (0.42) | ALDH1A1MYCWDR5CYP11B1CYP11B2 | |
| SCHEMBL8181288 | 0.79 | — | — | |
| SCHEMBL10216075 | 0.72 | — | — | |
| SCHEMBL28183847 | 0.70 | ALDH1A1 (0.44) | USP2USP8USP5USP4USP7 | |
| SCHEMBL18474339 | 0.68 | — | — | |
| SCHEMBL4408306 | 0.67 | ALDH1A1 (0.64) | USP2USP8USP5USP4USP7 | |
| SCHEMBL9620162 | 0.66 | CYP1A2 (0.48) | ALDH1A1MAPTCYP11B1CYP11B2HPGD | |
| SCHEMBL6495730 | 0.64 | — | — | |
| SCHEMBL16707560 | 0.63 | ALDH1A1 (0.55) | USP2USP8USP5USP4USP7 | |
| SCHEMBL16707585 | 0.63 | ALDH1A1 (0.46) | USP2USP8USP5USP4USP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10588896-B2 | Agents for the treatment of retroviral infectious diseases | IMMUNOLOGIK GMBH (DE) | 2020-03-17 | — | — | US | disclosed |
| US-10588896-B2 | Agents for the treatment of retroviral infectious diseases | IMMUNOLOGIK GMBH (DE) | 2020-03-17 | — | — | US | disclosed |
| US-20170202814-A1 | AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES | IMMUNOLOGIK GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| US-20170202814-A1 | AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES | IMMUNOLOGIK GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| EP-3166604-A1 | SUBSTANCES FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES | Immunologik GmbH (DE) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016004917-A1 | SUBSTANCES FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES | IMMUNOLOGIK GMBH (DE) | 2016-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202814-A1 | AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES | USP3, USP28, USP5 | USP2 10/4885USP8 15/4885USP5 3/4885 |
| US-10588896-B2 | Agents for the treatment of retroviral infectious diseases | USP3, USP28, USP5 | USP2 10/4885USP8 15/4885USP5 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.